Hawthorn (Crataegus spp.) from botanical source to phytopreparations

Sofija Djordjević, Nada Ćujić Nikolić

DOI: http://dx.doi.org/10.5937/leksir2141063D


The usage of hawthorn preparations has a long history in the traditional treatment of heart failure, which is considered as the inability of a weakened heart to supply peripheral tissues with the required amount of oxygen and nutrients. The leaf, flower, and fruit of the hawthorn, due to the presence of bioactive compounds such as flavonoids, procyanidins, organic acids, amines, etc., are showing a wide range of the effects on the cardiovascular system. The leaf and flower have a positive monograph in Commission E, as well as the EMA monograph, but only for traditional use. Numerous clinical studies have been conducted to evaluate the beneficial effects of dry hawthorn extracts on heart diseases. There are a large number of phytopreparations in various galenic forms on the market trade. According to the recent guidelines, usage of hawthorn preparations as a monotherapy in heart failure is not recommended. Instead, it should be used as an adjunct therapy.


Genus Crataegus, C. monogyna, C. oxyacantha, cardiotonics, heart failure, phytopreparations

Full Text:



AHA, American Heart Association. (1994). Revisions to classification of functional capacity and objective assessment of patients with diseases of the heart. Circulation. 90(1):644–5.

Alirezalu, A., Ahmadi, N., Salehi, P., Sonboli, A., Alirezalu, K., Khaneghah, A.M., Barba, F.J., Munekata, P.E.S. and Lorenzo, J.M. (2020). Physicochemical Characterization, Antioxidant Activity, and Phenolic Compounds of Hawthorn (Crataegus spp.) Fruits Species for Potential Use in Food Applications, Foods, 9(4), 436. https://doi.org/10.3390/foods9040436

Arslan, R. and Bektas, N. (2018). Potential Antithrombotic Effect of Crataegus Species. Indian Journal of Pharmaceutical Education and Research. 52(4s), Suppl 2, S155–157. DOI: 10.5530/ijper.52.4s.93

Bisset, N.G. and Wichtl, M. (Eds). (2001). Herbal Drugs and Phytopharmaceutical, Medpharm GmbH Scientific Publishers, Stuttgart.

Blumenthal, M. ed. (1998). The Complete German Commission E Monographs. Therapeutic Guide to Herbal Medicines. American Botanical Council, Austin, Texas.

Bradley, P. ed. (2006). British Herbal Compendium – A handbook of scientific information on widely used plant drugs. Vol 2. British Herbal Medicine Association, Bournemouth.

Cloud, A., Vilcins, D. and McEwen, B. (2020). The effect of hawthorn (Crataegus spp.) on blood pressure: A systematic review. Advances in integrative medicine. 7(3), 167–175. https://doi.org/10.1016/j.aimed.2019.09.002

DAB 10 (1993). Deutscher Pharmacopoea. Deutsches Arzneibuch, 10th ed., 3rd suppl. Stuttgart: Deutscher Apotheker Verlag.

Djordjevic, S. (2017). From Medicinal Plant Raw Material to Herbal Remedies, in: Hany El – Shemy (Ed.), Aromatic and Medicinal Plants – Back to Nature, In Tech, Rijeka, 169–217. DOI: 10.5772/63696, ISBN: 978-953-51-2978-3, Print ISBN: 978-953-51-2977–6.

Edwards, J.E., Brown, P.N., Talent, N., Dickinson, T.A. and Shipley P.R. (2012). A review of the chemistry of the genus Crataegus. Phytochemistry. 79, 5–26.

EMA, European Medicines Agency. (2016a). Committee on Herbal Medicinal Products (HMPC). Assessment report on Crataegus spp., folium cum flore. Report No.: EMA/HMPC/ 159076/2014, London.


EMA, European Medicines Agency. (2016b). Committee on Herbal Medicinal Products (HMPC). European Union herbal monograph on Crataegus spp., folium cum flore. London: Report No.: EMA/HMPC/159075/2014.


ESC. (2012). Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal, 33(1787–1847).

ESCOP Monographs. (2009). Crataegi fructus, Hawthorn Berries, Second edition Suplement 2009, European Scientific Cooperative on Phytotherapy, Devon and Thieme, Stuutgart and New York.

ESCOP Monographs. (2003). Crataegi folium cum flore, Hawthorn Leaf and Flower. Second edition, European Scientific Cooperative on Phytotherapy, Devon, and Thieme, Stuutgart and New York.

Halver, J., Wenzel, K., Sendker, J., Garcia, C.C., Erdelmeier, C.A.J., Willems, E., Mercola, M., Symma, N., Köenemann, S., Koch, E., Hensel, A. and Schade, D. (2019). Crataegus Extract WS(R) 1442 Stimulates Cardiomyogenesis and Angiogenesis from Stem Cells: A Possible New Pharmacology for Hawthorn? Frontiers in Pharmacology. 10, article 1357, p.18. https://doi.org/10.3389/fphar.2019.01357

Hänsel, R., Sticher, O. and Steinegger, E. (1999). Pharmakognosie-Phytopharmazie. Springer-Verlag, Berlin, Heidelberg.

Holubarsch, C.J.F., Colucci, W.S. and Eha, J. (2018). Benefit-Risk Assessment of Crataegus Extract WS 1442: An Evidence-Based Review. American Journal of Cardiovascular Drugs. 18(1), 25–36


Jančić, R. and Lakušić, B. (2017). Botanika Farmaceutika, Lento, Belgrade.

Josifović, M. ed. (1972). Flora of SR Serbia, volume IV, SANU, Belgrade.

Kaul, R. (1998). Der Weißdorn: Botanik, Inhaltsstoffe, Qualitätskontrolle, Pharmakologie, Toxikologie und Klinik. Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart.

Konjević, R. and Tatić, B. (2006). Plant names dictionary, NNK Internacional, Belgrade.

Kovačević, N. (2002). Pharmacognosy Basics, Srpska školska knjiga, Belgrade.

Kumar, D., Arya, V., Ali Bhat, Z., Ahmad Khan, N. and D. N. Prasad, D.N. (2012). The genus Crataegus: chemical and pharmacological perspectives. Revista Brasileira de Farmacognosia–Brasilian Journal of Pharmacognosy. 22(5), 1187–1200. DOI:10.1590/S0102-695X2012005000094

Ljubuncic, P., Portnaya, I., Cogan, U., Azaizeh, H. and Bomzon, A. (2005). Antioxidant activity of Crataegus aronia aqueous extract used in traditional Arab medicine in Israel. Journal of Ethnopharmacology. 101(1-3), 153–161. https://doi.org/10.1016/j.jep.2005.04.024

Lund, J.A., Brown, P.N. and Shipley, P.R. (2020). Quantification of North American and European Crataegus flavonoids by nuclear magnetic resonance spectrometry. Fitoterapia. 143:104537. https://doi.org/10.1016/j.fitote.2020.104537

Muradoglu, F., Gursoy, S. and Yildiz, K. (2019). Quantification Analysis of Biochemical and Phenolic Composition in Hawthorn (Crataegus spp.) Fruits. Erwerbs-Obstbau, 61(2), 189-194. https://doi.org/10.1007/s10341-018-00415-z

Niederseer, D., Ledl-Kurkowski, E., Kvita, K., Funk, P. and Niebauer, J. (2019). Safety and effects of Crataegus Extract WS 1442 and Nordic walking on lipid profile and endothelial function: A randomized, partially blinded pilot study in overweight volunteers, Acta Clinica Croatica, 58(4), 604–614. https://doi.org/10.20471/acc.2019.58.04.06

Orhan, I.E. (2018). Phytochemical and Pharmacological Activity Profile of Crataegus oxyacantha L. (Hawthorn) - A Cardiotonic Herb. Current medicinal chemistry. 25(37), 4854–4865. doi: 10.2174/0929867323666160919095519.

PDR for Herbal Medicines. (2000). Medical Economics Company, Montvale, New Jersey.

Petrović, S. and Kukić-Marković, J. (2008). Herbal and traditional medicines for treatment of cardiovascular system disorders, Arhiv za farmaciju. 58, 419–431.

Petrović, S. (2003). The use of hawthorn preparations in treatment of heart failure, Arhiv za farmaciju. 373–385.

Ph Eur (2014a). European Pharmacopoeia 8th ed. 2014 (2014a) (8.1). Council of Europe, Strasbourg, 01/2010:1432.

Ph Eur (2014b). European Pharmacopoeia 8th ed. 2014 (2014b) (8.1). Council of Europe, Strasbourg, 04/2013:1220.

Ph Eur (2014c). European Pharmacopoeia 8th ed. 2014 (2014c) (8.1). Council of Europe, Strasbourg, 01/2010:1865.

Ph Eur (2014d). European Pharmacopoeia 8th ed. 2014 (2014d) (8.1). Council of Europe, Strasbourg, 01/2008:1864.

Rote Liste. (2020). Arzneimittelverzeichnis für Deutschland. Frankfurt/Main: Rote Liste® Service GmbH, 2020.

Rote Liste. (2007). Arzneimittelinformationen für Deutschland. Frankfurt/Main: Rote Liste® Service GmbH, 2008.

Sagaradze, V.A., Babaeva, E.Yu., Ufimov, R.A., Trusov, N.A. and Kalenikova, E.I. (2019). Study of the variability of rutin, vitexin, hyperoside, quercetin in "Crataegi folium cum flore" of hawthorn (Crataegus L.) species from Russian flora. Journal of Applied Research on Medicinal and Aromatic Plants. 15, Article Number: 100217. https://doi.org/10.1016/j.jarmap.2019.100217

Sarić, M. (1989). Medicinal plants of SR Serbia, SANU, Belgrade.

Sarić, M. ed. (1986). Flora of SR Serbia, Volume X (2), Supplement to the Flora of SR Serbia with new data on plant species, SANU, Belgrade.

Schulz, V., Hänsel, R. and Tyler, V.E. (2004). Rational phytotherapy. A physician's guide to herbal medicine. 4th ed., Springer-Verlag: Berlin, Heidelberg, New York.

Simonović, D. (1959). Botanical dictionary, plant names, Naučno delo, SANU, Belgrade.

Stepanović-Petrović, R. and Micov, A. (2011). Therapy of heart failure, in: Ugrešić, N. (Ed), Pharmacotherapy for pharmacists, Faculty of Pharmacy, University of Belgrade, Belgrade, pp. 79–103.

Tadić, V., Dobrić, S., Marković, G., Ðordević, S., Arsić, I., Menković, N. and Stević, T. (2008). Anti-inflammatory, gastroprotective, free-radical-scavenging, and antimicrobial activities of hawthorn berries ethanol extract. Journal of Agricultural and Food Chemistry. 56(17), 7700–7709. DOI: 10.1021/jf801668c

Tasić, S., Šavikin, K. and Menković, N. (2009). A guide through the world of medicinal herbs, Alexandria, Belgrade.

Tassell, M.C., Kingston, R., Gilroy D., Lehane M. and Furey A. (2010). Hawthonn (Crataegus spp.) in the treatment of cardiovascular disease. Pharmacognosy Reviews. 4(7), 32–41. doi: 10.4103/0973-7847.65324

Tucakov, J. (1996). Herbal treatment - Phytotherapy, Prosveta, Belgrade.

Tutin, T.G., Heywood, V.H., Burges, N.A., Moore, D.M., Valentine, D.H., Walters, S.M. and Webb, D.A. (1968). Flora Europaea, Volume 2, Cambridge at the University Press, Cambridge.

WHO Monographs on Selected Medicinal Plants. (1999). Volume 2, World Health Organization, Geneva.

Yalcin Dokumaci, K., Uslu, N., Haciseferogullari, H. and Ornek, M. N. (2021). Determination of Some Physical and Chemical Properties of Common Hawthorn (Crataegus monogyna Jacq. var. monogyna), Erwerbs-Obstbau, 63, 99–106. https://doi.org/10.1007/s10341-021-00545-x

Yang, B. and Liu, P. (2012). Composition and health effects of phenolic compounds in hawthorn (Crataegus spp.) of different origins. Journal of the Science of Food and Agriculture. 92(8), 1578–1590.

doi: 10.1002/jsfa.5671.

Yusuf, J.B. and Mericli, A.H. (2016). Pharmacological activities of Crataegus species: A review. International Journal of Multidisciplinary Research and Development. 3(4), 73–76.

Zorniak, M., Szydlo, B. and Krzeminski, T.F. (2017). Craraegus special extract WS 1442: Up-to-date review of experimental and clinical experiences. Journal of physiology and pharmacology. 68(4), 521–526. https://www.researchgate.net/publication/321668871


  • There are currently no refbacks.

Copyright (c) 2021 Sofija Djordjević, Nada Ćujić Nikolić

ISSN 0455-6224 (Print)
ISSN 2560-3965 (Online)

Creative Commons License Except where otherwise noted, the content on this site is licensed under a Creative Commons Attribution 4.0 International License.